Episode 14 - Raphael Ognar, CEO & Co-Founder NKILT Therapeutics episode artwork

EPISODE · Sep 10, 2024 · 49 MIN

Episode 14 - Raphael Ognar, CEO & Co-Founder NKILT Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry. we have an incredible episode lined up with a phenomenal guest, Raphael Ognar! Raphael is the President & CEO, and Co-Founder of NKILT Therapeutics, a biotech company developing innovative cell therapies to target leukemias and solid tumors. With over 25 years in the pharma and biotech industries, Raphael has a wealth of experience in oncology, hematology, and cell therapy. We'll explore the origin of NKILT, how Raphael found the right partners, and the challenges of securing funding for early-stage biotechs. He'll also share his journey at companies like Celgene and BMS, how he handles pressure, and his decision-making process as a CEO. Enjoy and stay tuned.

Episode metadata supplied by the publisher feed · Published Sep 10, 2024

Embed this episode

NOW PLAYING

Episode 14 - Raphael Ognar, CEO & Co-Founder NKILT Therapeutics

0:00 49:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 49 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on September 10, 2024.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!